French diagnostics suffers from poor recognition
This article was originally published in Clinica
The importance of the IVD industry is not recognised by either doctors or patients in France, claims Claude Buffard, president of the French diagnostic industry association, SFRL. He blames in part the lack of opportunity to explain the benefits of diagnostics to doctors and patients. "The physician considers a diagnostic test as something supplementary," he told Clinica.
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.